GLP-1 Market
LLY $1137.82 ▲ +0.2% NVO $41.71 ▼ -1.9% PFE $27.46 ▼ -0.3% VKTX $29.52 ▼ -1.4% KLRA $12.70 ▼ -5.6% GPCR $35.50 ▼ -8.9% RHHBY $55.15 ▲ +0.4%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Anti-thymocyte globulin

Company
St. Jude Children's Research Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
63 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

63 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 17, 2026

Find a Clinical Trial Near Me

See recruiting studies for Anti-thymocyte globulin and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01624805

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

    Not yet reported M.D. Anderson Cancer Center 140 participants Est. completion 2029-06-30 1 site Stand-alone
    Other conditions: Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT01861106

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

    Not yet reported National Cancer Institute (NCI) 144 participants Est. completion 2028-12-31 1 site
    Other conditions: GATA2, Immunodeficiency, MDS
    View official trial listing →
  • Recruiting NCT NCT01949129

    Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

    Not yet reported, Not yet reported St. Anna Kinderkrebsforschung 1800 participants Est. completion 2030-06-01 119 sites
    Other conditions: Acute Lymphoblastic Leukaemia
    View official trial listing →
  • Recruiting NCT NCT02741102

    Uterine Transplant in Absolute Uterine Infertility (AUIF)

    Not yet reported, Not yet reported Brigham and Women's Hospital 3 participants Est. completion 2028-01 1 site
    Other conditions: Female Infertility
    View official trial listing →
  • Recruiting NCT NCT02828592

    Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia

    Not yet reported Northside Hospital, Inc. 20 participants Est. completion 2028-08-31 2 sites Stand-alone
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Recruiting NCT NCT03121001

    Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

    Not yet reported University of Illinois at Chicago 50 participants Est. completion 2029-05 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Recruiting NCT NCT03630211

    Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

    Not yet reported Paul Szabolcs 8 participants Est. completion 2028-08-01 3 sites
    Other conditions: Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease, Pulmonary Hypertension
    View official trial listing →
  • Recruiting NCT NCT03707262

    Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor

    Not yet reported, Not yet reported Jeffrey Veale, MD 15 participants Est. completion 2027-05 1 site
    Other conditions: Renal Transplant Rejection, Tolerance, Kidney Transplant
    View official trial listing →
  • Recruiting NCT NCT03852407

    Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

    Not yet reported University of Liege 114 participants Est. completion 2038-11-01 10 sites
    Other conditions: Acute Myeloid Leukemia in Remission, Myelodysplastic Syndromes, Chronic Myeloid Leukemia in Remission, Myeloproliferative Syndrome, Myeloproliferative Disorder, Acute Lymphoid Leukemia in Remission, Multiple Myeloma, Chronic Lymphoid Leukemia, Non Hodgkin Lymphoma, Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT03943238

    TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation

    Not yet reported Stanford University 22 participants Est. completion 2029-12-01 2 sites Stand-alone
    Other conditions: Living Donor Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT03980769

    Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

    Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2028-07-01 1 site Stand-alone
    Other conditions: Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
    View official trial listing →
  • Recruiting NCT NCT04047628

    Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 156 participants Est. completion 2029-10 23 sites Stand-alone
    Other conditions: Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis
    View official trial listing →
  • Recruiting NCT NCT04083183

    Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2028-01-09 1 site
    Other conditions: Non-Malignant Neoplasm
    View official trial listing →
  • Recruiting NCT NCT04224558

    Stem Cell Transplantation in Crohn's Disease

    Not yet reported, Not yet reported Cedars-Sinai Medical Center 15 participants Est. completion 2027-09-30 1 site Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Recruiting NCT NCT04304820

    Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 80 participants Est. completion 2033-12-18 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Recruiting NCT NCT04558736

    Haploidentical HCT for Severe Aplastic Anemia

    Not yet reported St. Jude Children's Research Hospital 21 participants Est. completion 2030-07-01 1 site Stand-alone
    Other conditions: Aplastic Anemia, Bone Marrow Failure Syndrome
    View official trial listing →
  • Recruiting NCT NCT04784052

    Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

    Not yet reported, Not yet reported Porteus, Matthew, MD 18 participants Est. completion 2028-12 1 site
    Other conditions: Fanconi Anemia
    View official trial listing →
  • Recruiting NCT NCT04989491

    Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

    Not yet reported University Hospital, Strasbourg, France 120 participants Est. completion 2029-12-01 1 site
    Other conditions: Epstein-Barr Virus Infections
    View official trial listing →
  • Recruiting NCT NCT05086003

    Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction

    Not yet reported Rabin Medical Center 20 participants Est. completion 2026-12-31 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Recruiting NCT NCT05385432

    Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies

    Not yet reported University Hospital, Tours 244 participants Est. completion 2030-12-30 1 site
    Other conditions: Renal Transplant Rejection, Induction Therapy
    View official trial listing →
  • Recruiting NCT NCT05525507

    Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

    Not yet reported University of California, Los Angeles 10 participants Est. completion 2026-12 1 site
    Chronic kidney disease Other conditions: End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Recruiting NCT NCT05735717

    MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

    Not yet reported Masonic Cancer Center, University of Minnesota 70 participants Est. completion 2030-11-30 1 site Stand-alone
    Other conditions: Hematologic Malignancy, Acute Leukemia, Remission, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, AML, TP53, Intrachromosomal Amplification of Chromosome 21, Cytogenetic Abnormality, CNS Leukemia, Minimal Residual Disease, Myelodysplasia, Juvenile Myelomonocytic Leukemia, Somatic Mutation, PTPN11 Gene Mutation, N-RAS Gene Amplification, Neurofibromatosis 1, NF1 Mutation, CBL Gene Mutation, Monosomy 7, Chromosome Abnormality, Fetal Hemoglobin, Lymphoblastic Lymphoma, High Grade Non-Hodgkin's Lymphoma, Adult
    View official trial listing →
  • Recruiting NCT NCT05743400

    Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation

    Not yet reported Hospices Civils de Lyon 35 participants Est. completion 2025-04-25 2 sites
    Other conditions: Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy
    View official trial listing →
  • Recruiting NCT NCT05832515

    AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis

    Not yet reported St. Petersburg State Pavlov Medical University 200 participants Est. completion 2026-12-01 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Recruiting NCT NCT05917405

    Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

    Not yet reported Nantes University Hospital 302 participants Est. completion 2028-09-14 23 sites
    Other conditions: Acute Myeloid Leukemia in Remission
    View official trial listing →
  • Recruiting NCT NCT06041893

    Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide

    Samsung Medical Center 20 participants Est. completion 2025-12-31 1 site
    Other conditions: Haploidentical Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT06055608

    Advancing Transplantation Outcomes in Children

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 200 participants Est. completion 2028-06-30 21 sites Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Recruiting NCT NCT06158828

    Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

    Not yet reported, Not yet reported Washington University School of Medicine 68 participants Est. completion 2030-05-31 1 site
    Other conditions: AML, Childhood, Aml, Acute Myeloid Leukemia, Pediatric, Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06198842

    Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome

    Not yet reported Federal Research Institute of Pediatric Hematology, Oncology and Immunology 10 participants Est. completion 2029-01-31 1 site
    Other conditions: Nijmegen Breakage Syndrome
    View official trial listing →
  • Recruiting NCT NCT06199427

    PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

    Not yet reported Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100 participants Est. completion 2027-12-31 1 site
    Other conditions: Inborn Errors of Immunity
    View official trial listing →
  • Recruiting NCT NCT06252870

    Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation

    Not yet reported Nantes University Hospital 82 participants Est. completion 2028-07-18 3 sites
    Other conditions: Graft Versus Host Disease, Hematologic Malignancy
    View official trial listing →
  • Recruiting NCT NCT06412497

    MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

    Not yet reported Masonic Cancer Center, University of Minnesota 60 participants Est. completion 2036-05-01 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia, Paroxysmal Nocturnal Hemoglobinuria
    View official trial listing →
  • Recruiting NCT NCT06430788

    A Study of Emapalumab for Pediatric Aplastic Anemia

    Not yet reported Memorial Sloan Kettering Cancer Center 35 participants Est. completion 2029-05-21 6 sites Stand-alone
    Other conditions: Aplastic Anemia, Cytopenia, Hypocellular Marrow
    View official trial listing →
  • Recruiting NCT NCT06455319

    Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

    Not yet reported University of Florida 60 participants Est. completion 2030-08 2 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Recruiting NCT NCT06504225

    EVEROLD LONG TERM FOLLOW-UP

    University Hospital, Brest 260 participants Est. completion 2025-08-01 14 sites
    Other conditions: Transplant; Complication, Failure
    View official trial listing →
  • Recruiting NCT NCT06512545

    Modified Second Haplo-transplantation for Graft Failure

    Not yet reported Peking University People's Hospital 12 participants Est. completion 2026-06-30 1 site
    Other conditions: Graft Failure, Stem Cell Transplant Complications
    View official trial listing →
  • Recruiting NCT NCT06517641

    Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

    Not yet reported Medical College of Wisconsin 60 participants Est. completion 2029-02-01 25 sites
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Recruiting NCT NCT06571825

    RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

    Not yet reported He Huang 118 participants Est. completion 2028-02-28 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT06572462

    ATG Individualized Dosing Model in URD-PBSCT.

    Not yet reported Chinese PLA General Hospital 30 participants Est. completion 2025-06-30 1 site
    Other conditions: Cytomegalovirus Infections, Infection Reactivation, Stem Cell Transplant Complications
    View official trial listing →
  • Recruiting NCT NCT06674382

    Haplo-HSCT for Myelofibrosis

    Not yet reported Peking University People's Hospital 39 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT06809075

    Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 10 participants Est. completion 2026-12 1 site
    Other conditions: Kidney Disease, Kidney Transplant, Kidney Transplant Candidates
    View official trial listing →
  • Recruiting NCT NCT06869265

    Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia

    Not yet reported Peking University People's Hospital 56 participants Est. completion 2029-04-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia (AML), High Risk Acute Myeloid Leukemia(AML), Relapsed/Refractory Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Recruiting NCT NCT06895538

    Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy

    Not yet reported, Not yet reported Peking University First Hospital 24 participants Est. completion 2027-02-28 1 site
    Other conditions: Leukemia, MDS, Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06904131

    A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors

    Not yet reported Obstetrics & Gynecology Hospital of Fudan University 20 participants Est. completion 2027-12-31 1 site
    Other conditions: Gynecological Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06972069

    Tolerance Through Mixed Chimerism (Sip-Tego)

    Not yet reported Tatsuo Kawai, MD, PhD 12 participants Est. completion 2030-12-31 1 site
    Other conditions: Kidney Failure, Transplant Recipient (Kidney), Transplant Tolerance, Immunosuppresion, Immunosuppression After Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT06984536

    Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT

    Not yet reported Peking University People's Hospital 40 participants Est. completion 2026-07-31 1 site
    Other conditions: Myelodysplastic Syndrome, Acute Leukemia
    View official trial listing →
  • Recruiting NCT NCT07052370

    TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 30 participants Est. completion 2030-12 1 site
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Recruiting NCT NCT07061574

    A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

    Not yet reported, Not yet reported City of Hope Medical Center 120 participants Est. completion 2031-04-15 10 sites
    Other conditions: Type 1 Diabetes, New Onset
    View official trial listing →
  • Recruiting NCT NCT07101588

    Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial

    Not yet reported Chinese PLA General Hospital 200 participants Est. completion 2028-12-30 1 site
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
    View official trial listing →
  • Recruiting NCT NCT07108530

    Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study

    Not yet reported Shanxi Bethune Hospital 50 participants Est. completion 2027-08-06 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT07183878

    Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)

    Not yet reported First Affiliated Hospital of Zhejiang University 138 participants Est. completion 2028-08-20 1 site
    Other conditions: Acute Myeloid Leukemia, High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndromes, High-Risk Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT07216391

    Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 60 participants Est. completion 2030-05-30 6 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT07257419

    CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

    Not yet reported St. Jude Children's Research Hospital 70 participants Est. completion 2035-12 1 site Stand-alone
    Other conditions: Relapsed Pediatric ALL, Hematopoietic Cell Transplantation, Hematologic Malignancy
    View official trial listing →
  • Recruiting NCT NCT07269041

    Immune Tolerance Induction After Liver Transplantation

    Not yet reported, Not yet reported University of California, Los Angeles 12 participants Est. completion 2033-01 1 site Stand-alone
    Other conditions: Liver Transplantation, Immune Tolerance, Immune Tolerance/Drug Effects, Graft Survival, Hematopoietic Stem Cell, Chimerism, Immunosuppression After Liver Transplantation, Immunosuppression Disorders, End Stage Liver Disease
    View official trial listing →
  • Recruiting NCT NCT07284641

    Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

    Not yet reported Paul Szabolcs 25 participants Est. completion 2031-02-01 1 site
    Other conditions: Common Variable Immunodeficiency (CVID), Primary Immune Regulatory Disorder, Immune Dysregulation, DiGeorge Syndrome, STAT 1 Gain of Function, STAT 3 Gain of Function, Hypomorphic RAG1 Deficiency, CD40 Ligand Deficiency, Mendelian Susceptibility to Mycobacterial Disease, GATA2 Associated Immunodeficiency, CD40 Deficiency, Hypomorphic RAG2 Deficiency, Immune Dysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome, Omenn Syndrome, Chronic Granulomatous Disease
    View official trial listing →
  • Recruiting NCT NCT07412470

    A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

    Not yet reported, Not yet reported Sanofi 526 participants Est. completion 2033-08-15 26 sites Stand-alone
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Recruiting NCT NCT07570745

    Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 82 participants Est. completion 2029-05-01 1 site Stand-alone
    Other conditions: Graft-Versus-Host Disease(GVHD), Bone Marrow Transplantation
    View official trial listing →
  • Recruiting NCT NCT07588360

    Haplo-Cord HSCT for AML/MDS

    Not yet reported Fujian Medical University Union Hospital 82 participants Est. completion 2029-06-30 4 sites
    Other conditions: MDS (Myelodysplastic Syndrome), AML (Acute Myeloid Leukemia)
    View official trial listing →
  • Recruiting NCT NCT07607197

    Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)

    Not yet reported, Not yet reported Hospital Universitari Vall d'Hebron Research Institute 10 participants Est. completion 2028-06 1 site
    Other conditions: Kidney Failure, Chronic, Kidney Transplantation, Alloimmunization, HLA Sensitization, End Stage Cronic Kidney Disease, Highly Sensitized Patients Awaiting Kidney Transplant
    View official trial listing →
  • Recruiting NCT NCT07648992

    Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell Transplantation

    Not yet reported Daihong Liu 324 participants Est. completion 2029-12-30 1 site Stand-alone
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT07677306

    Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT

    Not yet reported Peking University People's Hospital 120 participants Est. completion 2028-06-30 1 site
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT07689630

    Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 186 participants Est. completion 2028-05 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Hematologic Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07791576

    Population PK-guided ATG Dosing in Haplo-HSCT

    Not yet reported Chinese PLA General Hospital 63 participants Est. completion 2027-12-30 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00000597

    Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1988-12
    Other conditions: Anemia, Aplastic, Hematologic Diseases, Pancytopenia, Blood Disease
    View official trial listing →
  • Completed NCT NCT00001626

    Comparing Therapies for the Treatment of Severe Aplastic Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 33 participants Est. completion 2008-03-03 1 site
    Other conditions: Severe Aplastic Anemia (SAA)
    View official trial listing →
  • Completed NCT NCT00001749

    Medical Treatment for Diamond Blackfan Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 25 participants Est. completion 2005-07 1 site
    Other conditions: Fanconi's Anemia, Hematologic Disease
    View official trial listing →
  • Completed NCT NCT00001839

    A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

    Not yet reported National Institutes of Health Clinical Center (CC) 182 participants Est. completion 2000-05 1 site
    Other conditions: Hematologic Diseases, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00002534

    Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2003-04 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00002718

    T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia

    Not yet reported Memorial Sloan Kettering Cancer Center 31 participants Est. completion 2008-10 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00002809

    Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer

    Not yet reported Temple University 10 participants Est. completion 2003-12 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00003270

    Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported Roswell Park Cancer Institute 20 participants Est. completion 2017-10-16 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00003335

    Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

    Not yet reported Case Comprehensive Cancer Center 44 participants Est. completion 2012-01 1 site
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00003336

    Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

    Not yet reported Case Comprehensive Cancer Center 6 participants Est. completion 2006-02 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00003396

    Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported University of Maryland, Baltimore 42 participants Est. completion 2002-12 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00003398

    Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported University of Maryland, Baltimore 45 participants Est. completion 2000-05 1 site
    Other conditions: Anemia, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00003662

    Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

    Not yet reported Roswell Park Cancer Institute 90 participants Est. completion 2001-01 15 sites
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Thymic Carcinoma
    View official trial listing →
  • Completed NCT NCT00003816

    Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

    Not yet reported, Not yet reported Roswell Park Cancer Institute 361 participants Est. completion 2019-07-12 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Nonmalignant Neoplasm, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00004145

    Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported University of Chicago 16 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00004255

    Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

    Not yet reported, Not yet reported Chimeric Therapies Est. completion 2003-05 15 sites
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00004323

    Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia

    Not yet reported National Center for Research Resources (NCRR) 10 participants 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00004474

    Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia

    Not yet reported Roswell Park Cancer Institute 224 participants Est. completion 2007-08 4 sites Stand-alone
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Terminated NCT NCT00005852

    Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute Est. completion 2007-07
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00005853

    Biological Therapy in Treating Patients With Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2005-08 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00005893

    Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders

    Not yet reported Fairview University Medical Center 1 site
    Other conditions: Neutropenia, Sickle Cell Anemia, Thalassemia Major, Red-Cell Aplasia, Pure
    View official trial listing →
  • Completed NCT NCT00005898

    Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia

    Not yet reported, Not yet reported University of Minnesota 30 participants 1 site
    Other conditions: Fanconi's Anemia
    View official trial listing →
  • Terminated NCT NCT00006054

    Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

    Not yet reported Fairview University Medical Center Est. completion 2002-12 1 site
    Other conditions: Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome, Common Variable Immunodeficiency, Graft Versus Host Disease, X-Linked Lymphoproliferative Syndrome, Familial Erythrophagocytic Lymphohistiocytosis, Hemophagocytic Lymphohistiocytosis, X-linked Agammaglobulinemia, Wiskott-Aldrich Syndrome, Chronic Granulomatous Disease, X-linked Hyper IgM Syndrome, Severe Combined Immunodeficiency, Leukocyte Adhesion Deficiency Syndrome, Virus-Associated Hemophagocytic Syndrome
    View official trial listing →
  • Status unknown NCT NCT00006055

    Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases

    Not yet reported Fairview University Medical Center 10 participants 1 site
    Obstructive sleep apnea Other conditions: Purpura, Schoenlein-Henoch, Graft Versus Host Disease, Anemia, Hemolytic, Autoimmune, Rheumatoid Arthritis, Churg-Strauss Syndrome, Hypersensitivity Vasculitis, Wegener's Granulomatosis, Systemic Lupus Erythematosus, Giant Cell Arteritis, Pure Red Cell Aplasia, Juvenile Rheumatoid Arthritis, Autoimmune Thrombocytopenic Purpura, Takayasu Arteritis
    View official trial listing →
  • Completed NCT NCT00006379

    Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

    Not yet reported Case Comprehensive Cancer Center 58 participants Est. completion 2011-10 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Precancerous/Nonmalignant Condition, Small Intestine Cancer
    View official trial listing →
  • Completed NCT NCT00007787

    Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 350 participants Est. completion 2004-03 1 site
    Other conditions: Kidney Transplantation, Chronic Allograft Nephropathy
    View official trial listing →
  • Completed NCT NCT00010335

    Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

    Not yet reported Fred Hutchinson Cancer Center 6 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Systemic Sclerosis, Systemic Lupus Erythematosus, Dermatomyositis, Juvenile Rheumatoid Arthritis, Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT00016419

    S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

    Not yet reported SWOG Cancer Research Network 130 participants Est. completion 2007-01 94 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00016458

    Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis

    Not yet reported Fred Hutchinson Cancer Center 20 participants 3 sites
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT00017550

    Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome

    Not yet reported Genzyme, a Sanofi Company Est. completion 2003-11 28 sites
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00017641

    Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus

    Not yet reported Northwestern Memorial Hospital 10 participants 2 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00025038

    Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia

    Not yet reported National Cancer Institute (NCI) 100 participants 1 site Stand-alone
    Other conditions: Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00035880

    Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease

    Not yet reported, Not yet reported Abgenix 95 participants Est. completion 2003-06 1 site
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Terminated NCT NCT00040651

    Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients

    Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15 participants Est. completion 2007-03 1 site
    Other conditions: Scleroderma, Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT00053989

    NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

    Not yet reported Roswell Park Cancer Institute 41 participants Est. completion 2018-07-19 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Fanconi Anemia, Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00054340

    Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center Est. completion 2006-09 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00061360

    Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 77 participants Est. completion 2015-09-08 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00065260

    Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 54 participants Est. completion 2016-02-05 1 site Stand-alone
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00068523

    Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies

    Not yet reported Case Comprehensive Cancer Center 10 participants 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00070135

    Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

    Not yet reported Alliance for Clinical Trials in Oncology 121 participants Est. completion 2016-06-15 21 sites Stand-alone
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00072969

    A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 132 participants Est. completion 2005-08 1 site
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00076570

    Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 31 participants Est. completion 2012-08 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00101140

    Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

    Not yet reported Eastern Cooperative Oncology Group
    Other conditions: Adult Acute Erythroid Leukemia, Adult Acute Monoblastic and Acute Monocytic Leukemia, Adult Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00105183

    EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection

    Not yet reported Neovii Biotech 223 participants Est. completion 2011-01 19 sites
    Other conditions: Chronic Obstructive Pulmonary, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis, Bronchiectasis, Pulmonary Vascular Disease
    View official trial listing →
  • Completed NCT NCT00112645

    Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

    Not yet reported Milton S. Hershey Medical Center 10 participants Est. completion 2011-02 1 site
    Other conditions: Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00113269

    Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients

    Not yet reported Astellas Pharma Inc 501 participants Est. completion 2009-03 29 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00113828

    Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies

    Not yet reported Massachusetts General Hospital 5 participants Est. completion 2007-03 1 site Stand-alone
    Other conditions: Lymphoma, Leukemia, Multiple Myeloma, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00114530

    Scleroderma: Cyclophosphamide or Transplantation

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2016-04 17 sites
    Other conditions: Scleroderma, Systemic, Sclerosis, Autoimmune Disease
    View official trial listing →
  • Completed NCT NCT00117689

    Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection

    Not yet reported Genzyme, a Sanofi Company 75 participants Est. completion 2007-12 16 sites
    Other conditions: Liver Dysfunction, Rejection, Transplant, Transplantation, Liver
    View official trial listing →
  • Completed NCT NCT00167219

    Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 15 participants Est. completion 2023-08-09 1 site Stand-alone
    Other conditions: Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT00176826

    T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 22 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome, Griscelli Syndrome, Immunologic Diseases, Langerhans-Cell Histiocytosis, Hematologic Diseases
    View official trial listing →
  • Completed NCT NCT00176852

    Stem Cell Transplant for Hemoglobinopathy

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 22 participants Est. completion 2020-01 1 site
    Other conditions: Sickle Cell Disease, Thalassemia, Severe Congenital Neutropenia, Diamond-Blackfan Anemia, Shwachman-Diamond Syndrome
    View official trial listing →
  • Completed NCT NCT00176904

    Stem Cell Transplant for Inborn Errors of Metabolism

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 135 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy, Gaucher's Disease, Fucosidosis, Wolman Disease, Niemann-Pick Disease, Batten Disease, GM1 Gangliosidosis, Tay Sachs Disease, Sandhoff Disease
    View official trial listing →
  • Completed NCT NCT00181142

    The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation

    Not yet reported, Not yet reported Johns Hopkins University 60 participants Est. completion 2004-12 1 site
    Other conditions: Patients Active and Listed for Lung Transplantation
    View official trial listing →
  • Completed NCT NCT00185640

    Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies

    Not yet reported Stanford University 303 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Blood Cancer, Leukemia
    View official trial listing →
  • Completed NCT NCT00185692

    Allogeneic Transplantation From Related Haploidentical Donors

    Not yet reported Stanford University 16 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Blood Cancer, Leukemia, Graft Versus Host Disease, Malignancy, CLL, NHL, Hodgkin's Disease, MDS
    View official trial listing →
  • Completed NCT NCT00186810

    Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease

    Not yet reported St. Jude Children's Research Hospital 15 participants Est. completion 2007-10 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00217386

    Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes

    Not yet reported Fred Hutchinson Cancer Center 30 participants 4 sites
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00228852

    IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency

    Not yet reported, Not yet reported Emory University Est. completion 2006-11 1 site
    Other conditions: T-Cell Immune Deficiency Diseases, Severe Combined Immunodeficiency
    View official trial listing →
  • Terminated NCT NCT00235781

    Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

    Not yet reported Washington University School of Medicine 90 participants Est. completion 2006-02 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00258427

    Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia

    Not yet reported Masonic Cancer Center, University of Minnesota 14 participants Est. completion 2020-10-10 1 site Stand-alone
    Other conditions: Fanconi Anemia
    View official trial listing →
  • Completed NCT NCT00260689

    Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 136 participants Est. completion 2016-05-04 1 site Stand-alone
    Other conditions: Immunosuppresion, Thrombocytopenia, Pancytopenia, Neutropenia
    View official trial listing →
  • Completed NCT NCT00261820

    Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 160 participants Est. completion 2005-01
    Other conditions: Graft Rejection, Kidney Failure, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00262886

    Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

    Not yet reported University of Rochester 35 participants 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00275509

    Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

    Not yet reported Johns Hopkins University 56 participants Est. completion 2010-06 1 site
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00275535

    The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

    Not yet reported Mayo Clinic 165 participants Est. completion 2008-12 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00275678

    Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies

    Not yet reported Mayo Clinic 15 participants 1 site
    Other conditions: Blood Stem Cell Transplant
    View official trial listing →
  • Terminated NCT NCT00278512

    Hematopoietic Stem Cell Support in Vasculitis

    Not yet reported Northwestern University 7 participants Est. completion 2016-06 1 site
    Other conditions: Vasculitis
    View official trial listing →
  • Completed NCT NCT00278525

    Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma

    Not yet reported Northwestern University 19 participants Est. completion 2012-12 1 site
    Other conditions: SYSTEMIC SCLERODERMA
    View official trial listing →
  • Completed NCT NCT00278629

    Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy

    Not yet reported Northwestern University 80 participants Est. completion 2019-11-04 1 site
    Other conditions: Chronic Inflammatory Demyelinating Polyneuropathy
    View official trial listing →
  • Terminated NCT NCT00281879

    Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

    Not yet reported OHSU Knight Cancer Institute 200 participants Est. completion 2008-03 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unusual Cancers of Childhood
    View official trial listing →
  • Completed NCT NCT00286624

    Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation

    Not yet reported, Not yet reported University of Minnesota 6 participants Est. completion 2006-08 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus, Hypoglycemia
    View official trial listing →
  • Terminated NCT NCT00290628

    Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 43 participants Est. completion 2007-04 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Diamond-blackfan Anemia, Fanconi Anemia, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00295971

    Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease

    Not yet reported University of California, San Francisco 21 participants Est. completion 2011-12 2 sites Stand-alone
    Other conditions: Congenital Amegakaryocytic Thrombocytopenia, Leukemia, Myelodysplastic Syndromes, Severe Congenital Neutropenia
    View official trial listing →
  • Status unknown NCT NCT00295997

    Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

    Not yet reported University of California, San Francisco 35 participants 2 sites
    Other conditions: Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Terminated NCT NCT00301860

    Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic Cancer

    Not yet reported University of California, San Francisco 8 participants Est. completion 2007-11 1 site
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00303667

    Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 50 participants Est. completion 2011-03 1 site
    Other conditions: Acute Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT00305708

    Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

    Not yet reported, Not yet reported University of California, San Francisco 40 participants Est. completion 2004-07 1 site
    Other conditions: Congenital Amegakaryocytic Thrombocytopenia, Diamond-blackfan Anemia, Fanconi Anemia, Leukemia, Severe Congenital Neutropenia, Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT00315133

    Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus

    Not yet reported, Not yet reported University of Sao Paulo 25 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT00317408

    Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma

    Not yet reported European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma 96 participants 98 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00317798

    Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

    Not yet reported University of Rochester 18 participants Est. completion 2011-04 1 site
    Other conditions: Drug/Agent Toxicity by Tissue/Organ, Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Status unknown NCT NCT00319657

    Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs

    Not yet reported, Not yet reported Stanford University 15 participants Est. completion 2026-07 1 site
    Other conditions: Immune Tolerance
    View official trial listing →
  • Completed NCT NCT00331162

    Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation

    Not yet reported Wake Forest University Health Sciences 222 participants Est. completion 2011-11-28 1 site
    Other conditions: Graft Rejection
    View official trial listing →
  • Completed NCT NCT00354120

    Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

    Not yet reported, Not yet reported Gruppo Italiano Trapianto di Midollo Osseo 121 participants Est. completion 2011-08 22 sites
    Other conditions: Acute Myeloblastic Leukemia, Lymphoblastic Leukemia, Myelodysplasia, Chronic Myeloid Leukemia, Myelofibrosis, Lympho-proliferative Diseases
    View official trial listing →
  • Terminated NCT NCT00354419

    Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant

    Not yet reported Fred Hutchinson Cancer Center 30 participants 1 site Stand-alone
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00365287

    Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 148 participants Est. completion 2005-12
    Other conditions: Breast Cancer, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00376480

    Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

    Not yet reported Dana-Farber Cancer Institute 19 participants Est. completion 2018-05-16 6 sites Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00378768

    Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma

    Not yet reported Fred Hutchinson Cancer Center 12 participants Est. completion 2007-06 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00385788

    Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease

    Not yet reported M.D. Anderson Cancer Center 52 participants Est. completion 2016-08 1 site
    Other conditions: Hodgkin's Disease
    View official trial listing →
  • Terminated NCT NCT00392782

    Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease

    Not yet reported Masonic Cancer Center, University of Minnesota 24 participants Est. completion 2011-05 9 sites Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00402558

    Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

    Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2014-04 1 site
    Other conditions: Myelodysplastic Syndrome, Leukemia
    View official trial listing →
  • Completed NCT NCT00407160

    A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients

    The University of Texas Medical Branch, Galveston 21 participants Est. completion 2011-01 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Terminated NCT NCT00409695

    Thymoglobulin (ATG) Dose Finding Study

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 1 participants Est. completion 2007-08 1 site
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Terminated NCT NCT00424489

    Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis

    Not yet reported Northwestern University 9 participants Est. completion 2016-06 1 site
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Completed NCT NCT00425802

    Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

    Not yet reported Memorial Sloan Kettering Cancer Center 61 participants Est. completion 2016-10-28 1 site
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00427336

    Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia

    Not yet reported M.D. Anderson Cancer Center 9 participants Est. completion 2009-08 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00434811

    Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2014-05 8 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00434850

    Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 14 participants Est. completion 2013-11 3 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT00436761

    Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

    Not yet reported Milton S. Hershey Medical Center 20 participants 1 site
    Other conditions: Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00448201

    Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

    Not yet reported UNC Lineberger Comprehensive Cancer Center 71 participants Est. completion 2012-05-23 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00448357

    Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

    Not yet reported, Not yet reported UNC Lineberger Comprehensive Cancer Center 54 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00455013

    A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation

    Not yet reported Bristol-Myers Squibb 93 participants Est. completion 2012-08 17 sites
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00455312

    Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 36 participants Est. completion 2016-06 1 site
    Other conditions: Dyskeratosis Congenita, Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00464555

    Strategies to Improve Islet Survival

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2014-02 2 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT00466843

    Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

    Not yet reported Office of Rare Diseases (ORD) 54 participants Est. completion 2010-02 4 sites
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00468117

    Efficacy of Islet After Kidney Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2017-07-05 10 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00471848

    Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia

    Not yet reported European Society for Blood and Marrow Transplantation 35 participants Est. completion 2013-02 14 sites
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00475020

    Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome

    Not yet reported M.D. Anderson Cancer Center 63 participants Est. completion 2017-10-04 1 site
    Other conditions: Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00476229

    Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies

    Not yet reported M.D. Anderson Cancer Center 20 participants Est. completion 2009-05 1 site
    Other conditions: Lymphoma, Leukemia
    View official trial listing →
  • Terminated NCT NCT00481832

    Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

    Not yet reported Stanford University 50 participants Est. completion 2017-03-30 1 site Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Terminated NCT NCT00482053

    Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

    Not yet reported Stanford University 3 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Lymphoma, B-cell, Lymphoma, Non-Hodgkin, Diffuse Large B-cell Lymphoma (DLBCL), Malignant Lymphoma, Non-Hodgkin
    View official trial listing →
  • Terminated NCT NCT00489281

    Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 43 participants Est. completion 2018-12-29 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00498316

    Cord Blood Expansion on Mesenchymal Stem Cells

    Not yet reported M.D. Anderson Cancer Center 98 participants Est. completion 2016-10 1 site
    Other conditions: Myelodysplastic Syndrome, Leukemia
    View official trial listing →
  • Terminated NCT NCT00499889

    Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

    Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2009-11 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00506129

    Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

    Not yet reported M.D. Anderson Cancer Center 33 participants Est. completion 2015-06 1 site
    Other conditions: Lymphoma, Disorder Related to Bone Marrow Transplantation
    View official trial listing →
  • Terminated NCT NCT00506948

    Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

    Not yet reported M.D. Anderson Cancer Center 13 participants Est. completion 2010-10 1 site
    Other conditions: Hematological Malignancies, Myelodysplastic Syndrome, Leukemia, Lymphoma
    View official trial listing →
  • Terminated NCT NCT00515099

    Study of Antithymocyte Globulin for Treatment of New-onset T1DM

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 58 participants Est. completion 2013-07 9 sites
    Other conditions: New-onset Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00521430

    Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

    Not yet reported Asan Medical Center 30 participants Est. completion 2008-09 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Nonmalignant Neoplasm, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00533442

    Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients

    Not yet reported University of Miami 170 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00545519

    A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

    Not yet reported Washington University School of Medicine 6 participants Est. completion 2008-03 1 site
    Other conditions: Relapsed Or Refractory Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT00550992

    Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia

    Not yet reported Dutch Childhood Oncology Group 445 participants 13 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00556933

    Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

    Not yet reported University of Nebraska 180 participants Est. completion 2011-06-01 1 site Stand-alone
    Other conditions: End-stage Renal Disease
    View official trial listing →
  • Status unknown NCT NCT00564538

    A Study of Thymoglobulin and Tacrolimus in Liver Transplant

    Not yet reported University of Nebraska 100 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Liver Transplantation, Liver Disease, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00566488

    Parathyroid and Thymus Transplantation in DiGeorge #931

    Not yet reported Sumitomo Pharma Switzerland GmbH 25 participants Est. completion 2019-12 1 site
    Other conditions: DiGeorge Syndrome, Hypoparathyroidism, Complete DiGeorge Syndrome
    View official trial listing →
  • Completed NCT NCT00566696

    Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies

    Not yet reported St. Jude Children's Research Hospital 73 participants Est. completion 2020-02-06 1 site Stand-alone
    Other conditions: Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML), Juvenile Myelomonocytic Leukemia (JMML), Hemoglobinuria, Paroxysmal Nocturnal (PNH), Hodgkin Lymphoma, Lymphoma, Non-Hodgkin (NHL), Myelodysplastic Syndrome (MDS)
    View official trial listing →
  • Terminated NCT NCT00568633

    Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

    Not yet reported Stanford University 58 participants Est. completion 2015-12-31 5 sites Stand-alone
    Other conditions: Leukemia, Myeloid, Leukemia, Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Completed NCT NCT00579527

    Phase I/II Thymus Transplantation With Immunosuppression #950

    Not yet reported, Not yet reported Sumitomo Pharma Switzerland GmbH 14 participants Est. completion 2017-12-31 1 site Stand-alone
    Other conditions: DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly, Complete DiGeorge Syndrome, Complete Atypical DiGeorge Syndrome
    View official trial listing →
  • Completed NCT NCT00582933

    Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor

    Not yet reported Memorial Sloan Kettering Cancer Center 96 participants Est. completion 2009-04 1 site
    Other conditions: Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma, Allogeneic Marrow Transplant
    View official trial listing →
  • Completed NCT NCT00589563

    Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

    Not yet reported City of Hope Medical Center 32 participants Est. completion 2012-02 2 sites Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Secondary Myelofibrosis, Small Intestine Cancer
    View official trial listing →
  • Withdrawn NCT NCT00592306

    Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation

    Not yet reported University of California, Los Angeles Est. completion 2010-09 1 site
    Other conditions: Lung Transplant
    View official trial listing →
  • Terminated NCT NCT00593645

    Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation

    Not yet reported Washington University School of Medicine 7 participants Est. completion 2009-07 1 site
    Other conditions: Myelodysplastic Syndromes, Acute Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT00596947

    Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant

    Not yet reported University of Pennsylvania 18 participants Est. completion 2009-03 1 site
    Other conditions: Transplants and Implants
    View official trial listing →
  • Completed NCT NCT00603954

    Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings

    Not yet reported University of Liege 107 participants Est. completion 2016-07 11 sites
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT00610961

    Induction Related BK Viremia in Renal Transplant Patients

    University of Florida 60 participants Est. completion 2009-11 1 site
    Other conditions: Disease Due to BK Polyomavirus, Transplantation Infection, Disorder Related to Transplantation
    View official trial listing →
  • Completed NCT NCT00611351

    Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

    Not yet reported University of Nebraska 5 participants Est. completion 2008-09-17 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Secondary Myelofibrosis
    View official trial listing →
  • Terminated NCT NCT00617929

    Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

    Not yet reported Masonic Cancer Center, University of Minnesota 12 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT00629798

    Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

    Not yet reported Memorial Sloan Kettering Cancer Center 64 participants Est. completion 2020-10-20 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Advanced Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00630253

    Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 31 participants Est. completion 2020-10-10 1 site Stand-alone
    Other conditions: Fanconi Anemia
    View official trial listing →
  • Terminated NCT NCT00635024

    Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma

    Not yet reported Mayo Clinic 1 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Terminated NCT NCT00669890

    Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML

    Not yet reported New York Medical College 12 participants Est. completion 2013-12 1 site
    Other conditions: Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Terminated NCT NCT00670410

    Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma

    Not yet reported Columbia University 15 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Terminated NCT NCT00672204

    Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes

    Not yet reported, Not yet reported University of Minnesota 23 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT00682292

    Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk

    Not yet reported University Hospital, Lille 227 participants Est. completion 2006-11 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00697684

    Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant

    Not yet reported Beth Israel Deaconess Medical Center 29 participants Est. completion 2023-11 2 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Relapsed/Refractory Chronic Lymphocytic Leukemia, Relapsed/Refractory Non Hodgkin's Lymphoma, Hodgkins Disease, Relapsed Refractory Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT00706680

    Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol

    Not yet reported University Health Network, Toronto 30 participants Est. completion 2009-06 3 sites
    Other conditions: Diabetes, Graft Rejection
    View official trial listing →
  • Completed NCT NCT00709592

    Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

    Not yet reported Virginia Commonwealth University 42 participants Est. completion 2017-06-28 1 site Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma, Leukemia, Multiple Myeloma, Acute Myeloid Leukemia, Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00714480

    Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment

    Not yet reported Swedish Medical Center 3 participants Est. completion 2009-12 1 site
    Other conditions: Renal Transplantation, Immunosuppression
    View official trial listing →
  • Active, not recruiting NCT NCT00716066

    Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

    Not yet reported Fred Hutchinson Cancer Center 53 participants Est. completion 2030-01-31 3 sites Stand-alone
    Other conditions: Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune, Multiple Sclerosis Transplant, MS Stem Cell Transplant, Multiple Sclerosis Stem Cell Transplant, Stiff Person Syndrome, HCT for Neurologic Autoimmune Disorders, CIDP Transplant, Myasthenia Gravis Transplant, Autoimmune Nervous System Disorder, Central Nervous System Vasculitis, Cerebellar Degeneration, Chronic Inflammatory Demyelinating Polyneuropathy, Lambert Eaton Myasthenic Syndrome, Myasthenia Gravis, Neuromyelitis Optica, Opsoclonus Myoclonus Syndrome, Rasmussen Subacute Encephalitis
    View official trial listing →
  • Terminated NCT NCT00720629

    Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 8 participants Est. completion 2013-12 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00724022

    Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation

    Not yet reported University Hospital Freiburg 600 participants Est. completion 2014-07 25 sites
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00731328

    Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome

    Not yet reported Asan Medical Center 15 participants Est. completion 2013-12 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Nonmalignant Neoplasm, Paroxysmal Nocturnal Hemoglobinuria
    View official trial listing →
  • Completed NCT NCT00732316

    Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

    Not yet reported Asan Medical Center 54 participants Est. completion 2011-05 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00750126

    Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported University Hospital, Clermont-Ferrand 30 participants Est. completion 2009-04 1 site
    Other conditions: Solid Tumors, Hematologic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT00750971

    Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)

    Not yet reported Charite University, Berlin, Germany 30 participants Est. completion 2020-08 8 sites
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00771745

    Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients

    Not yet reported University of Cincinnati 11 participants Est. completion 2010-07 1 site
    Other conditions: Renal Transplant Rejection, Transplants and Implants
    View official trial listing →
  • Completed NCT NCT00774527

    Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT

    Not yet reported Cooperative Study Group A for Hematology 82 participants Est. completion 2011-01 1 site
    Other conditions: Bone Marrow Failure Syndromes
    View official trial listing →
  • Completed NCT NCT00782821

    Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients

    Not yet reported University of Cincinnati 40 participants Est. completion 2013-03 2 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00787722

    Hematopoietic Stem Cell Transplant in Devic's Disease

    Not yet reported, Not yet reported Northwestern University 13 participants Est. completion 2018-11 1 site
    Other conditions: Devic's Disease
    View official trial listing →
  • Completed NCT NCT00787761

    Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

    Not yet reported Northside Hospital, Inc. 24 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00802568

    Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment

    Not yet reported Institut Paoli-Calmettes 48 participants 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00806598

    Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome

    Not yet reported M.D. Anderson Cancer Center 53 participants Est. completion 2012-06 1 site
    Other conditions: Myelodysplastic Syndrome, Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00806767

    Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer

    Not yet reported Institut Paoli-Calmettes 82 participants 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00822770

    Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 47 participants Est. completion 2012-10 1 site
    Other conditions: Stem Cell Transplantation, Leukemia
    View official trial listing →
  • Terminated NCT NCT00827099

    Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

    Not yet reported Northside Hospital, Inc. 5 participants Est. completion 2009-11 1 site
    Other conditions: Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00841724

    Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

    Not yet reported Nantes University Hospital 82 participants Est. completion 2012-01 3 sites
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT00842699

    Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab

    Brigham and Women's Hospital 40 participants Est. completion 2011-03 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT00849888

    Serum-Free Thymus Transplantation in DiGeorge Anomaly

    Not yet reported Sumitomo Pharma Switzerland GmbH 2 participants Est. completion 2011-02 Stand-alone
    Other conditions: DiGeorge Anomaly
    View official trial listing →
  • Withdrawn NCT NCT00853424

    A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease

    Not yet reported University of British Columbia Est. completion 2010-12
    Other conditions: Diabetic Retinopathy, Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT00854139

    Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)

    Not yet reported Massachusetts General Hospital 10 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Multiple Myeloma, End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00856388

    Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

    Not yet reported Roswell Park Cancer Institute 62 participants Est. completion 2019-03-13 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Aplastic Anemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Fanconi Anemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Paroxysmal Nocturnal Hemoglobinuria, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00857389

    Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

    Not yet reported M.D. Anderson Cancer Center 60 participants Est. completion 2019-03-09 1 site
    Other conditions: Stem Cell Transplantation, Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00859131

    Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists

    Not yet reported Medical University of South Carolina 200 participants Est. completion 2014-07 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00861536

    Comparison of ATG to Thymoglobuline in Renal Transplantation

    Not yet reported University Hospital, Basel, Switzerland 40 participants Est. completion 2015-02 1 site
    Other conditions: Transplantation, Kidney
    View official trial listing →
  • Completed NCT NCT00863148

    Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)

    Not yet reported Nantes University Hospital 30 participants Est. completion 2013-06 6 sites
    Other conditions: MDS, AML, ALL, BAL
    View official trial listing →
  • Withdrawn NCT NCT00874315

    Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

    Not yet reported Nationwide Children's Hospital Est. completion 2012-06 4 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00880815

    Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant

    Not yet reported M.D. Anderson Cancer Center 60 participants Est. completion 2019-05-28 1 site Stand-alone
    Other conditions: CD20 Positive, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00882323

    Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)

    Not yet reported The Korean Society of Pediatric Hematology Oncology 33 participants Est. completion 2012-10 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT00882895

    Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma

    Not yet reported Washington University School of Medicine 18 participants Est. completion 2028-06-01 1 site Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT00885833

    Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)

    Not yet reported, Not yet reported The Korean Society of Pediatric Hematology Oncology 5 participants Est. completion 2012-03 1 site
    Other conditions: Wiskott-Aldrich Syndrome
    View official trial listing →
  • Completed NCT NCT00886522

    Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 23 participants Est. completion 2013-05 1 site
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Status unknown NCT NCT00887042

    Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML

    Not yet reported, Not yet reported The Korean Society of Pediatric Hematology Oncology 35 participants Est. completion 2012-05 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00888628

    Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients

    Not yet reported, Not yet reported Massachusetts General Hospital 7 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type I
    View official trial listing →
  • Completed NCT NCT00890500

    Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

    Not yet reported Fate Therapeutics 12 participants Est. completion 2013-10 2 sites
    Other conditions: Hematologic Malignancies, Allogeneic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00894049

    A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation

    Not yet reported Institut Paoli-Calmettes 148 participants Est. completion 2013-02 5 sites
    Other conditions: Allograft, Allogeneic Cell Transplantaion, Hematological Malignancy, Solid Tumor
    View official trial listing →
  • Completed NCT NCT00896493

    Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

    Not yet reported Stanford University 38 participants Est. completion 2022-12 1 site Stand-alone
    Other conditions: Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Cutaneous T-cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT00899431

    Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)

    Not yet reported M.D. Anderson Cancer Center 39 participants Est. completion 2018-10-07 1 site
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00899847

    Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

    Not yet reported Stanford University 9 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Transplantation, Homologous, Transplantation, Autologous, Multiple Myeloma, Blood and Marrow Transplant (BMT)
    View official trial listing →
  • Completed NCT NCT00906204

    Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation

    Not yet reported Wright State University 99 participants Est. completion 2014-07 4 sites Stand-alone
    Other conditions: End-Stage Renal Disease, Kidney Failure
    View official trial listing →
  • Completed NCT NCT00914849

    Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies

    Not yet reported Washington University School of Medicine 68 participants Est. completion 2012-02 1 site
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Terminated NCT NCT00915811

    Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin

    Not yet reported King's College Hospital NHS Trust 20 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute
    View official trial listing →
  • Terminated NCT NCT00916045

    Pilot Study of Unrelated Cord Blood Transplantation

    Not yet reported King's College Hospital NHS Trust 40 participants Est. completion 2012-03 1 site
    Other conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Leukemia, Lymphoblastic, Acute, Lymphoma, Non-Hodgkin, Hodgkin Disease, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00923364

    Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC

    Not yet reported National Cancer Institute (NCI) 19 participants Est. completion 2017-02-26 1 site Stand-alone
    Other conditions: MDS, Immunodeficiency, GATA2
    View official trial listing →
  • Completed NCT NCT00944749

    Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 23 participants Est. completion 2016-12 1 site
    Other conditions: Anemia, Aplastic, Anemia, Hypoplastic
    View official trial listing →
  • Terminated NCT NCT00961142

    Haploidentical Stem Cell Transplantation With CD3/CD19 Depletion and Reduced Intensity Conditioning in Patients With Acute Leukemia

    Not yet reported University Hospital Tuebingen 23 participants Est. completion 2015-12-30 8 sites
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00970073

    Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant

    Not yet reported The Cleveland Clinic 30 participants Est. completion 2015-12 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00972101

    Infusion of Expanded Cord Blood T Cells

    Not yet reported M.D. Anderson Cancer Center Est. completion 2011-09 Stand-alone
    Other conditions: Stem Cell Transplantation, Leukemia, Lymphoma, Pediatric Disorders
    View official trial listing →
  • Completed NCT NCT00990249

    Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center 120 participants Est. completion 2016-05 1 site
    Other conditions: Leukemia, Lymphoma, Allogeneic Haematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia
    View official trial listing →
  • Withdrawn NCT NCT00995059

    Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma

    Not yet reported, Not yet reported Mayo Clinic Stand-alone
    Other conditions: Multiple Myeloma, Refractory Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT01015742

    Unrelated Double Umbilical Cord Blood Units Transplantation

    Not yet reported, Not yet reported Tehran University of Medical Sciences 10 participants Est. completion 2013-01 1 site
    Other conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myeloid, Chronic
    View official trial listing →
  • Completed NCT NCT01019876

    Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases

    Not yet reported, Not yet reported Columbia University 38 participants Est. completion 2021-09-07 1 site Stand-alone
    Other conditions: Bone Marrow Failure, Osteopetrosis, Fanconi Anemia, Severe Combined Immunodeficiency
    View official trial listing →
  • Completed NCT NCT01020539

    Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia

    Not yet reported Columbia University 18 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01028092

    mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation

    Not yet reported University Hospital, Brest 327 participants Est. completion 2014-07 18 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Terminated NCT NCT01037764

    Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)

    Not yet reported Asan Medical Center 100 participants Est. completion 2016-12 2 sites Stand-alone
    Other conditions: Acute Lymphoid Leukemia
    View official trial listing →
  • Terminated NCT NCT01044745

    Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported University of Nebraska 20 participants Est. completion 2017-10-10 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Graft Versus Host Disease, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01046955

    Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal Transplantation

    Not yet reported University of Miami 38 participants Est. completion 2008-12 1 site
    Other conditions: End-Stage Renal Disease, Living Donors
    View official trial listing →
  • Terminated NCT NCT01050764

    Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells

    Not yet reported, Not yet reported Everett Meyer 10 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Leukemia, Acute, Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL)
    View official trial listing →
  • Completed NCT NCT01081405

    Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation

    Not yet reported Fondazione EMN Italy Onlus 20 participants Est. completion 2022-11 1 site Stand-alone
    Other conditions: HEMATOLOGIC MALIGNANCIES
    View official trial listing →
  • Status unknown NCT NCT01087398

    Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis

    Not yet reported, Not yet reported Tehran University of Medical Sciences 10 participants Est. completion 2012-12 1 site
    Other conditions: Osteopetrosis
    View official trial listing →
  • Completed NCT NCT01093586

    Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Case Comprehensive Cancer Center 14 participants Est. completion 2015-12 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Erythroleukemia (M6a), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Pure Erythroid Leukemia (M6b), B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Burkitt Lymphoma, Childhood Acute Erythroleukemia (M6), Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Juvenile Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Previously Treated Myelodysplastic Syndromes, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Splenic Marginal Zone Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, T-cell Large Granular Lymphocyte Leukemia, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01099930

    Autologous Stem Cell Transplant for Multiple Sclerosis

    Not yet reported Ottawa Hospital Research Institute 24 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01104025

    Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis

    Not yet reported Children's Hospital Medical Center, Cincinnati 31 participants Est. completion 2016-04 15 sites
    Other conditions: Hemophagocytic Lymphohistiocytosis
    View official trial listing →
  • Completed NCT NCT01106157

    Reversing Type 1 Diabetes After it is Established

    Not yet reported, Not yet reported University of Florida 25 participants Est. completion 2019-07-16 3 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT01116232

    Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

    Not yet reported Barbara Ann Karmanos Cancer Institute 4 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Terminated NCT NCT01118013

    Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

    Not yet reported Alliance for Clinical Trials in Oncology 6 participants Est. completion 2013-08 10 sites Stand-alone
    Other conditions: Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT01131169

    Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

    Not yet reported Memorial Sloan Kettering Cancer Center 66 participants Est. completion 2020-05-15 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT01135537

    Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants

    Not yet reported The Hospital for Sick Children 30 participants Est. completion 2014-01 1 site
    Other conditions: Malignancy, Metabolic Disease, Genetic Disorder
    View official trial listing →
  • Status unknown NCT NCT01145976

    Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia

    Not yet reported Cooperative Study Group A for Hematology 98 participants Est. completion 2016-02 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01158118

    Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors

    Not yet reported Washington University School of Medicine 48 participants Est. completion 2016-12-31 1 site
    Other conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Lymphoma, Non-Hodgkin, Hodgkin Disease, Leukemia, Lymphocytic, Chronic, B-Cell, Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT01165762

    Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.

    Not yet reported Everett Meyer 25 participants Est. completion 2025-06-14 2 sites
    Other conditions: ESRD
    View official trial listing →
  • Completed NCT NCT01168219

    Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

    Not yet reported National Cancer Institute (NCI) 68 participants Est. completion 2020-02-01 17 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With Maturation, Adult Acute Myeloid Leukemia With Minimal Differentiation, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL, Adult Acute Myeloid Leukemia Without Maturation, Adult Acute Myelomonocytic Leukemia, Adult Erythroleukemia, Adult Pure Erythroid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01172418

    Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols

    Not yet reported University of Miami 200 participants Est. completion 2010-05 1 site
    Other conditions: Transplant; Failure, Kidney
    View official trial listing →
  • Completed NCT NCT01195194

    Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity.

    Not yet reported Josep M Grinyo 61 participants Est. completion 2013-06 2 sites
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT01217723

    Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

    Not yet reported McMaster University 198 participants Est. completion 2014-01 10 sites Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Status unknown NCT NCT01238328

    Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis

    Not yet reported, Not yet reported Tehran University of Medical Sciences 10 participants Est. completion 2012-12 1 site
    Other conditions: Mucopolysaccharidosis
    View official trial listing →
  • Status unknown NCT NCT01239563

    Thymoglobulin Induction in Kidney Transplant Recipients

    Not yet reported University of Oxford 40 participants Est. completion 2016-05 2 sites
    Other conditions: Kidney Transplantation, Ischemia-Reperfusion Injury
    View official trial listing →
  • Completed NCT NCT01246206

    Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

    Not yet reported Barbara Ann Karmanos Cancer Institute 21 participants Est. completion 2013-10 1 site
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT01266148

    SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance

    Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2012-12 6 sites
    Other conditions: Renal Function and Chronic Allograft Vasculopathy
    View official trial listing →
  • Completed NCT NCT01272817

    Nonmyeloablative Allogeneic Transplant

    Not yet reported Scripps Health 36 participants Est. completion 2015-10 1 site
    Other conditions: Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Waldenstrom Macroglobulinemia, Breast Cancer, Renal Cell Carcinoma, Melanoma, Sarcoma, Ovarian Cancer, Thymoma
    View official trial listing →
  • Completed NCT NCT01277770

    Studies of Kidney Transplant Outcome

    University of Minnesota 7500 participants Est. completion 2019-05-06 1 site
    Other conditions: Transplant Recipient (Kidney), Steroid-Free Maintenance Immunosuppression, Post-Transplant Infections, Thymoglobulin
    View official trial listing →
  • Terminated NCT NCT01279616

    A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease

    Not yet reported Nationwide Children's Hospital 8 participants Est. completion 2015-01 1 site
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT01295710

    Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

    Not yet reported Neovii Biotech 260 participants Est. completion 2015-10-15 28 sites
    Other conditions: GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01297972

    Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia

    Not yet reported, Not yet reported University of Sao Paulo 9 participants Est. completion 2013-11 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Terminated NCT NCT01312064

    De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction

    Not yet reported National Taiwan University Hospital 2 participants Est. completion 2012-04 1 site
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Terminated NCT NCT01318915

    Research Study of ATG and Rituximab in Renal Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2017-08-25 6 sites
    Other conditions: Renal Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01336296

    Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients

    Not yet reported University of Cincinnati 61 participants Est. completion 2014-04 1 site
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Terminated NCT NCT01339455

    Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica

    Not yet reported, Not yet reported University of Calgary 3 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Neuromyelitis Optica
    View official trial listing →
  • Completed NCT NCT01341899

    Efficacy and Safety Study of Autologous Hematopoietic Stem Cell Transplantation to Treat New Onset Type 1 Diabetes

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50 participants Est. completion 2015-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01346085

    Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation

    Not yet reported, Not yet reported Ospedale San Raffaele 10 participants Est. completion 2012-06 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01354301

    Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate

    Not yet reported Hospital do Rim e Hipertensão 300 participants Est. completion 2014-12 1 site
    Other conditions: Cytomegalovirus Infection, Renal Transplant Failure, Transplant; Complication, Rejection
    View official trial listing →
  • Completed NCT NCT01362452

    Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

    Not yet reported M.D. Anderson Cancer Center 5 participants Est. completion 2017-07-25 1 site
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT01390402

    Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Leukemia, Chronic Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT01392989

    Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

    Not yet reported Everett Meyer 44 participants Est. completion 2017-03-19 1 site
    Other conditions: Neural Tube Defects, Anemia, Leukemia, Myeloid, Bone Marrow Transplant Failure, Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders
    View official trial listing →
  • Completed NCT NCT01413100

    Scleroderma Treatment With Autologous Transplant (STAT) Study

    Not yet reported Fred Hutchinson Cancer Center 21 participants Est. completion 2024-09-11 12 sites Stand-alone
    Other conditions: Systemic Scleroderma
    View official trial listing →
  • Completed NCT NCT01455506

    PRO#0118: Decitabine Plus Mini Flu-Bu

    Not yet reported Hackensack Meridian Health 20 participants Est. completion 2013-12 1 site
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT01461837

    Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

    Not yet reported New York Medical College 21 participants Est. completion 2026-12 6 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT01471067

    Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    Not yet reported M.D. Anderson Cancer Center 33 participants Est. completion 2017-04-25 1 site
    Other conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Transplantation, Bone Marrow
    View official trial listing →
  • Completed NCT NCT01490723

    Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

    Not yet reported M.D. Anderson Cancer Center 20 participants Est. completion 2019-04-24 1 site
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT01499147

    Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

    Not yet reported University of Illinois at Chicago 100 participants Est. completion 2013-05 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia, Malignant Lymphoma, Hodgkin's Disease, Multiple Myeloma, Lymphocytic Leukemia, Myeloproliferative Disorder, Polycythemia Vera, Myelofibrosis, Aplastic Anemia
    View official trial listing →
  • Terminated NCT NCT01517984

    Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 52 participants Est. completion 2015-05 11 sites
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01530555

    Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia

    Not yet reported King Faisal Specialist Hospital & Research Center 35 participants Est. completion 2013-07 Stand-alone
    Other conditions: Acquired Aplastic Anaemia
    View official trial listing →
  • Terminated NCT NCT01556347

    Multi-Drug Desensitization Protocol for Heart Transplant Candidates

    Not yet reported Providence Health & Services 2 participants Est. completion 2016-05 1 site
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT01566656

    Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies

    Not yet reported Nantes University Hospital 15 participants Est. completion 2016-11-29 4 sites Stand-alone
    Other conditions: Haemato-lymphoid Malignancies or Syndromes in Whom Allogeneic Stem Cell Transplantation is Warranted
    View official trial listing →
  • Active, not recruiting NCT NCT01623167

    Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

    Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 207 participants Est. completion 2029-11-30 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Terminated NCT NCT01629511

    Allogeneic Stem Cell Transplant for CLL

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2018-04-25 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Richter Syndrome
    View official trial listing →
  • Completed NCT NCT01664910

    CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 27 participants Est. completion 2023-06-28 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Withdrawn NCT NCT01680055

    Collection of Blood and Bone Marrow From Patients With Aplastic Anemia for Analysis of Adhesion Molecules, Chemokines and Their Receptors

    Shandong University Est. completion 2012-11 1 site
    Other conditions: Aplastic Anemia, Healthy
    View official trial listing →
  • Terminated NCT NCT01685411

    Busulfan and Cyclophosphamide Followed By ALLO BMT

    Not yet reported Masonic Cancer Center, University of Minnesota 5 participants Est. completion 2020-02-10 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01701986

    Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 64 participants Est. completion 2024-06-05 1 site Stand-alone
    Other conditions: Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01729494

    Belatacept Early Steroid Withdrawal Trial

    Not yet reported University of Cincinnati 316 participants Est. completion 2019-12 8 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT01745913

    Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

    Not yet reported Weill Medical College of Cornell University 2 participants Est. completion 2015-04-29 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01751997

    Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors

    Not yet reported, Not yet reported Byung-Sik Cho 116 participants Est. completion 2019-12-31 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01758328

    Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma

    Not yet reported Memorial Sloan Kettering Cancer Center 29 participants Est. completion 2025-03-17 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT01759732

    Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia

    Not yet reported Asan Medical Center 10 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Acquired Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT01786018

    Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas

    Not yet reported Azienda Ospedaliera San Giovanni Battista 42 participants Est. completion 2015-02 1 site
    Other conditions: B-cell Lymphoma Refractory
    View official trial listing →
  • Completed NCT NCT01810588

    Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

    Not yet reported Weill Medical College of Cornell University 270 participants Est. completion 2026-03-24 2 sites Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Status unknown NCT NCT01811368

    Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

    Not yet reported Joseph Tuscano 20 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01844635

    Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAA

    Not yet reported Nagoya University 320 participants 1 site
    Other conditions: Acquired Aplastic Anemia.
    View official trial listing →
  • Status unknown NCT NCT01850108

    Non-Myeloablative Conditioning and Bone Marrow Transplantation

    Not yet reported Vanderbilt-Ingram Cancer Center 26 participants Est. completion 2024-12-31 3 sites
    Other conditions: Sickle Cell Disease, Hemoglobinopathies
    View official trial listing →
  • Terminated NCT NCT01856257

    Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 71 participants Est. completion 2016-04 3 sites Stand-alone
    Other conditions: Primary Renal Allograft Candidate, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01860170

    Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis

    Not yet reported, Not yet reported Corewell Health West 28 participants Est. completion 2018-03 1 site
    Other conditions: Hematological Malignancy
    View official trial listing →
  • Completed NCT NCT01883180

    ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

    Not yet reported Nanfang Hospital, Southern Medical University 412 participants Est. completion 2018-01 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation, Antithymocyte Globulin, Viral Infection
    View official trial listing →
  • Completed NCT NCT01895049

    Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

    Not yet reported Helio Tedesco Silva Junior 171 participants Est. completion 2017-03-07 1 site
    Other conditions: Kidney Transplantation, Cytomegalovirus
    View official trial listing →
  • Completed NCT NCT01895244

    Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis

    Not yet reported University Hospital Tuebingen 44 participants Est. completion 2024-06 1 site
    Other conditions: Scleroderma, Cardiac Involvement, Autologous Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT01939171

    Thymoglobulin in Cadaver Donor

    Not yet reported Instituto de Investigación Hospital Universitario La Paz 20 participants Est. completion 2012-02 2 sites
    Other conditions: Prevention of Kidney Injury Associated With Brain Death
    View official trial listing →
  • Status unknown NCT NCT01974674

    Allogeneic Islet Transplantation for the Treatment of Type 1 Diabetes

    Not yet reported Assistance Publique - Hôpitaux de Paris 19 participants Est. completion 2022-01 1 site
    Other conditions: Patients With Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT01983761

    Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

    Not yet reported, Not yet reported Targazyme, Inc. 25 participants 4 sites Stand-alone
    Other conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Myelodysplastic Syndrome (MDS), Non-Hodgkin's Lymphoma (NHL), Hodgkin's Lymphoma
    View official trial listing →
  • Terminated NCT NCT01994824

    Preemptive Therapy of GVHD

    Not yet reported University of Calgary 70 participants Est. completion 2021-09-27 1 site
    Other conditions: Graft-vs-host Disease
    View official trial listing →
  • Status unknown NCT NCT02028416

    Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia

    Not yet reported National Institute of Blood Disease Center, Pakistan 60 participants Est. completion 2017-12 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Terminated NCT NCT02029638

    BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 4 participants Est. completion 2017-09-06 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT02080195

    Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 participants Est. completion 2017-03-29 1 site
    Other conditions: Lupus Erythematosus, Graft-versus-host Disease
    View official trial listing →
  • Completed NCT NCT02083250

    Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant

    Not yet reported M.D. Anderson Cancer Center 70 participants Est. completion 2021-11-12 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02084446

    Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

    Not yet reported Ronaldo de Matos Esmeraldo, MD 120 participants Est. completion 2017-07 1 site
    Other conditions: Transplantation Infection, Cytomegalovirus Infections
    View official trial listing →
  • Status unknown NCT NCT02102854

    Single Dose rATG for Renal Allograft Rejection

    Not yet reported The Methodist Hospital Research Institute 30 participants Est. completion 2021-10 1 site
    Other conditions: Acute (Cellular) Renal Allograft Rejection
    View official trial listing →
  • Completed NCT NCT02122081

    Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    Not yet reported Sumithira Vasu 33 participants Est. completion 2022-09-06 1 site Stand-alone
    Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02129582

    Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Case Comprehensive Cancer Center 14 participants Est. completion 2020-03-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myelofibrosis, Myeloproliferative Syndrome
    View official trial listing →
  • Withdrawn NCT NCT02130817

    Belatacept in Kidney Transplantation of Moderately Sensitized Patients

    Not yet reported University of Wisconsin, Madison Est. completion 2015-10-09 1 site
    Other conditions: End Stage Renal Disease, Antibody Mediated Rejection
    View official trial listing →
  • Completed NCT NCT02137239

    Regimen Optimization Study

    Not yet reported Bristol-Myers Squibb 58 participants Est. completion 2019-05-02 20 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT02137876

    Effects of Thymoglobulin on Human B Cells

    Northwestern University Est. completion 2018-03 1 site
    Other conditions: Acute Humoral Rejections, Chronic Humoral Rejections, Transplant
    View official trial listing →
  • Completed NCT NCT02152345

    Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients

    Not yet reported Columbia University 57 participants Est. completion 2016-12-31 1 site
    Other conditions: Implant or Graft; Rejection
    View official trial listing →
  • Completed NCT NCT02158052

    Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

    Not yet reported Massachusetts General Hospital 2 participants Est. completion 2021-06-22 1 site Stand-alone
    Other conditions: Multiple Myeloma, Amyloidosis
    View official trial listing →
  • Completed NCT NCT02162420

    Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia

    Not yet reported Masonic Cancer Center, University of Minnesota 61 participants Est. completion 2025-03-11 1 site Stand-alone
    Other conditions: Dyskeratosis Congenita, Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02165007

    Haploidentical Hematopoietic Stem Cell Transplantation

    Not yet reported Catherine Bollard 7 participants Est. completion 2024-10 1 site Stand-alone
    Other conditions: Sickle Cell-thalassemia Disease, Thalassemia
    View official trial listing →
  • Completed NCT NCT02166177

    Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients

    Not yet reported, Not yet reported Guy's and St Thomas' NHS Foundation Trust 9 participants Est. completion 2018-01-22 1 site
    Other conditions: End-stage Liver Disease
    View official trial listing →
  • Active, not recruiting NCT NCT02171104

    MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis

    Not yet reported Masonic Cancer Center, University of Minnesota 149 participants Est. completion 2029-07-14 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome, Maroteaux Lamy Syndrome, Sly Syndrome, Alpha-Mannosidosis, Fucosidosis, Glycoprotein Metabolic Disorders, Sphingolipidoses, Recessive Leukodystrophies, Globoid Cell Leukodystrophy, Metachromatic Leukodystrophy, Niemann-Pick B, Niemann-Pick C Subtype 2, Sphingomyelin Deficiency, Peroxisomal Disorders, Adrenoleukodystrophy With Cerebral Involvement, Zellweger Syndrome, Neonatal Adrenoleukodystrophy, Infantile Refsum Disease, Acyl-CoA Oxidase Deficiency, D-Bifunctional Enzyme Deficiency, Multifunctional Enzyme Deficiency, Alpha-methylacyl-CoA Racmase Deficiency, Mitochondrial Neurogastrointestingal Encephalopathy, Severe Osteopetrosis, Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation), Inherited Metabolic Disorders
    View official trial listing →
  • Terminated NCT NCT02179359

    Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

    Not yet reported Masonic Cancer Center, University of Minnesota 38 participants Est. completion 2024-11-21 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Transfusion Dependent Alpha- or Beta- Thalassemia, Diamond Blackfan Anemia, Paroxysmal Nocturnal Hemoglobinuria, Glanzmann Thrombasthenia, Severe Congenital Neutropenia, Shwachman-Diamond Syndrome, Non-Malignant Hematologic Disorders
    View official trial listing →
  • Terminated NCT NCT02188719

    Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 15 participants Est. completion 2019-06-18 3 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02203396

    A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 40 participants Est. completion 2017-09 1 site Stand-alone
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02215200

    ATG-GCSF in New Onset Type 1 Diabetes

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 89 participants Est. completion 2018-08 13 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02224872

    Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18 participants Est. completion 2021-12 2 sites
    Other conditions: Severe Aplastic Anemia, Bone Marrow Failure Syndromes
    View official trial listing →
  • Withdrawn NCT NCT02225795

    Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.

    Not yet reported TriStar Health Est. completion 2019-12
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT02266888

    B Cell Induction in Pediatric Lung Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 2019-06-30 7 sites
    Other conditions: Lung Transplant
    View official trial listing →
  • Completed NCT NCT02267512

    Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients

    Not yet reported Astellas Pharma Inc 280 participants Est. completion 2015-12-31 14 sites
    Other conditions: De Novo Kidney Transplant Patients
    View official trial listing →
  • Status unknown NCT NCT02386332

    A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies

    Instituto de Investigacion Sanitaria La Fe 206 participants Est. completion 2020-03
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Withdrawn NCT NCT02409147

    Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center

    Not yet reported University of Nebraska Est. completion 2018-07-24
    Other conditions: Uterus Transplant
    View official trial listing →
  • Terminated NCT NCT02411084

    Study of BEGEDINA® vs "Conventional Treatment" for Treating Steroid-Resistant Acute GvHD

    Not yet reported Adienne SA 36 participants Est. completion 2017-07-31 27 sites
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT02424968

    CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

    Not yet reported Robert Lowsky 18 participants Est. completion 2021-04 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Hodgkin Lymphoma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02447822

    Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg)

    Not yet reported Asan Medical Center 154 participants Est. completion 2018-05
    Other conditions: Kidney Failure
    View official trial listing →
  • Completed NCT NCT02461121

    HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk

    Not yet reported The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 156 participants Est. completion 2013-05 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02462252

    Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome

    Not yet reported BioLineRx, Ltd. 11 participants Est. completion 2020-11 1 site Stand-alone
    Other conditions: Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT02464878

    Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

    Not yet reported Massachusetts General Hospital 2 participants Est. completion 2022-12 1 site
    Other conditions: Kidney Transplant, Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02483325

    Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood Diseases

    Not yet reported Institut Paoli-Calmettes 33 participants Est. completion 2020-03 1 site
    Other conditions: Hematological Diseases
    View official trial listing →
  • Completed NCT NCT02495077

    Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 290 participants Est. completion 2021-07-23 15 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT02500550

    Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

    Not yet reported Kiadis Pharma 15 participants Est. completion 2018-12-17 11 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT02540395

    Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation

    Not yet reported Prof. Dr. Petra Reinke 184 participants Est. completion 2020-10-31 8 sites
    Other conditions: Disorder Related to Renal Transplantation, Effects of Immunosuppressant Therapy
    View official trial listing →
  • Completed NCT NCT02544113

    A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver Transplantation

    Not yet reported The Cleveland Clinic 110 participants Est. completion 2020-01-03 4 sites
    Other conditions: Liver Failure
    View official trial listing →
  • Status unknown NCT NCT02561767

    Effect of BM-MSCs in DCD Kidney Transplantation

    Not yet reported, Not yet reported First Affiliated Hospital, Sun Yat-Sen University 120 participants Est. completion 2017-10 1 site
    Other conditions: Kidney Transplantation, Acute Kidney Tubular Necrosis
    View official trial listing →
  • Withdrawn NCT NCT02586831

    Diabetes Islet Preservation Immune Treatment

    Not yet reported, Not yet reported Camillo Ricordi and Jay Skyler Est. completion 2024-06-01 Added to GLP-1
    Other conditions: Diabetes Mellitus, Type 1, Hypoglycemia, Autoimmune Diseases, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02623309

    Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

    Not yet reported Institut Paoli-Calmettes 108 participants Est. completion 2021-03-12 14 sites
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Terminated NCT NCT02627573

    Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

    Not yet reported St. Petersburg State Pavlov Medical University 32 participants Est. completion 2019-04-03 1 site
    Other conditions: Leukemia, Chronic Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
    View official trial listing →
  • Status unknown NCT NCT02643589

    Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation

    Not yet reported Nanfang Hospital, Southern Medical University 200 participants Est. completion 2016-12 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT02656550

    Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Infertility

    Not yet reported Baylor Research Institute 38 participants Est. completion 2026-11 1 site
    Other conditions: Absolute Uterine Infertility
    View official trial listing →
  • Completed NCT NCT02661035

    Allo HSCT Using RIC for Hematological Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 156 participants Est. completion 2023-05-29 1 site
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Lymphoblastic Lymphoma, Burkitt's Lymphoma, Non-Hodgkin's Lymphoma, Multiple Myeloma, Myeloproliferative Syndromes, Hematological Diseases
    View official trial listing →
  • Completed NCT NCT02677181

    Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT

    Not yet reported Chinese PLA General Hospital 100 participants Est. completion 2022-04 1 site Stand-alone
    Other conditions: aGVHD
    View official trial listing →
  • Withdrawn NCT NCT02702960

    Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Est. completion 2018-01-03 1 site
    Other conditions: Fibrolamellar Hepatocellular Carcinoma, Hepatocellular Carcinoma (Fibrolamellar Variant), Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT02707393

    Allogeneic Stem Cell Transplantation for Children With CML

    Not yet reported, Not yet reported St. Anna Kinderkrebsforschung 13 participants Est. completion 2020-12-01 4 sites
    Other conditions: Chronic Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02722668

    UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    Not yet reported Masonic Cancer Center, University of Minnesota 15 participants Est. completion 2024-02-22 1 site Stand-alone
    Other conditions: Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Burkitt's Lymphoma, Natural Killer Cell Malignancies, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, Large-cell Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Relapsed Chronic Lymphocytic Leukemia, Relapsed Small Lymphocytic Lymphoma, Marginal Zone B-cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-cell Lymphoma, Prolymphocytic Leukemia, Bone Marrow Failure Syndromes, Myeloproliferative Neoplasms/Myelofibrosis, Biphenotypic/Undifferentiated/Prolymphocytic Leukemias, MRD Positive Leukemia, Leukemia or MDS in Aplasia, Relapsed T-Cell Lymphoma, Relapsed Multiple Myeloma, Plasma Cell Leukemia
    View official trial listing →
  • Terminated NCT NCT02728271

    Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome

    Not yet reported Mounzer Agha 1 participants Est. completion 2016-08-20
    Other conditions: Churg-Strauss Syndrome
    View official trial listing →
  • Completed NCT NCT02745717

    The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2021-12 1 site
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT02784561

    Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

    Not yet reported Chinese PLA General Hospital 80 participants Est. completion 2020-07 Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT02790515

    Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

    Not yet reported St. Jude Children's Research Hospital 170 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma, Chronic Myeloid Leukemia (CML), Juvenile Myelomonocytic Leukemia (JMML), Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma (NHL)
    View official trial listing →
  • Completed NCT NCT02821026

    Omental Islet Transplant

    Not yet reported, Not yet reported University of Alberta 4 participants Est. completion 2019-11-13 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02833805

    NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21 participants Est. completion 2021-07 1 site
    Other conditions: Severe Aplastic Anemia, Aplastic Anemia, Bone Marrow Failure, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT02838992

    ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia

    Not yet reported Jinan Military General Hospital 130 participants Est. completion 2019-07 1 site Stand-alone
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT02843841

    Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation

    Not yet reported Centre Hospitalier Universitaire de Besancon 63 participants Est. completion 2017-03-01 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT02845596

    Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

    Not yet reported Michael Pulsipher 40 participants Est. completion 2023-07-19 13 sites
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02857907

    Anti-thymocyte Globulin-induced Immune Senescence

    Centre Hospitalier Universitaire de Besancon 97 participants Est. completion 2013-01 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT02867800

    Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

    Not yet reported Monica Bhatia 24 participants Est. completion 2023-12-30 7 sites Stand-alone
    Other conditions: Sickle Cell Disease, Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT02876679

    Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

    Not yet reported Assistance Publique - Hôpitaux de Paris 94 participants Est. completion 2020-10-12 1 site
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Terminated NCT NCT02877082

    Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients

    Not yet reported Emory University 5 participants Est. completion 2017-07 1 site
    Other conditions: Acute Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Graft Versus Host Disease, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT02918292

    Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

    Not yet reported Medical College of Wisconsin 32 participants Est. completion 2021-08-17 28 sites
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT02928991

    Fludarabine Based RIC for Bone Marrow Failure Syndromes

    Not yet reported Children's Hospital of Philadelphia 25 participants Est. completion 2028-12 1 site
    Other conditions: Bone Marrow Failure Syndromes
    View official trial listing →
  • Status unknown NCT NCT02938741

    ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 130 participants Est. completion 2022-12 2 sites
    Other conditions: Lymphoblastic Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03000296

    Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease

    Not yet reported Beneficência Portuguesa de São Paulo 50 participants Est. completion 2024-12 1 site
    Other conditions: Crohn's Disease, Inflammatory Bowel Diseases, Gastroenteritis
    View official trial listing →
  • Completed NCT NCT03025698

    A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

    Not yet reported Novartis Pharmaceuticals 51 participants Est. completion 2025-01-27 20 sites
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT03079089

    Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders

    Not yet reported Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 40 participants Est. completion 2023-09-11 1 site
    Other conditions: Refractory or Relapsed Lymphoid Haemopathy
    View official trial listing →
  • Status unknown NCT NCT03088280

    Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen

    Not yet reported Hospital Geral de Fortaleza 200 participants Est. completion 2020-01 1 site
    Other conditions: Thymoglobulin Dose
    View official trial listing →
  • Completed NCT NCT03096782

    Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2022-09-20 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chemotherapy-Related Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Hodgkin Lymphoma, Langerhans Cell Histiocytosis, Minimal Residual Disease, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Myelodysplastic Syndrome, Small Lymphocytic Lymphoma, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Status unknown NCT NCT03225417

    Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.

    Not yet reported, Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 142 participants Est. completion 2024-12-31 8 sites
    Other conditions: Hematopoietic Stem Cell Transplantation, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT03240731

    HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease

    Not yet reported Centre Hospitalier Intercommunal Creteil 25 participants Est. completion 2024-04-08 7 sites
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Status unknown NCT NCT03246178

    Haploidentical Transplantation in Severe Aplastic Anemia

    Not yet reported Wu Xiaoxiong 60 participants Est. completion 2020-12-01 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT03249831

    A Blood Stem Cell Transplant for Sickle Cell Disease

    Not yet reported City of Hope Medical Center 3 participants Est. completion 2027-01-25 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies, Thalassemia, Anemia, Sickle Cell
    View official trial listing →
  • Completed NCT NCT03263559

    Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

    Not yet reported Medical College of Wisconsin 95 participants Est. completion 2025-01-29 32 sites
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Terminated NCT NCT03263767

    Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC

    Not yet reported Nantes University Hospital 47 participants Est. completion 2022-06-21 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT03292861

    The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients

    Not yet reported Cedars-Sinai Medical Center 60 participants Est. completion 2026-03-31 2 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Status unknown NCT NCT03295058

    Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients

    Not yet reported, Not yet reported Assiut University 50 participants Est. completion 2020-06
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT03318159

    Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients

    Not yet reported Seoul National University Hospital 20 participants Est. completion 2023-07-15 1 site
    Other conditions: Aplastic Anemia, Myelodysplastic Syndromes, Fungal Infection
    View official trial listing →
  • Status unknown NCT NCT03337568

    Allogeneic HCT Using Uniform Conditioning Regimen Regardless of Donors (MS, MU, or HF) for AML in Remission

    Asan Medical Center 110 participants Est. completion 2021-03-30 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT03357159

    Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation

    Not yet reported Sheba Medical Center 30 participants Est. completion 2024-12-01 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Terminated NCT NCT03367546

    Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 5 participants Est. completion 2022-12-19 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders, Cerebral Adrenoleukodystrophy, Inherited Metabolic Disorders
    View official trial listing →
  • Completed NCT NCT03377283

    Peri-operative rATG-perfusion of Solid Transplants

    Not yet reported Medical University Innsbruck 80 participants Est. completion 2016-02-24
    Other conditions: Organ Preservation Solutions
    View official trial listing →
  • Completed NCT NCT03388008

    Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

    Not yet reported Washington University School of Medicine 27 participants Est. completion 2022-08-31 2 sites Stand-alone
    Other conditions: Lung Transplant Rejection, Antibody-mediated Rejection
    View official trial listing →
  • Completed NCT NCT03393611

    CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

    Not yet reported Weill Medical College of Cornell University 14 participants Est. completion 2021-11-18 1 site Stand-alone
    Other conditions: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Relapsed Adult Acute Myeloid, Myelodysplastic Syndromes, Previously Treated
    View official trial listing →
  • Status unknown NCT NCT03395860

    Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100 participants Est. completion 2021-12-20 1 site
    Other conditions: Graft-versus-host-disease, Prophylaxis
    View official trial listing →
  • Status unknown NCT NCT03412409

    RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT

    Not yet reported Peking University People's Hospital 50 participants Est. completion 2025-09-01 1 site
    Other conditions: Acute Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT03468478

    Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation

    Not yet reported Hospital do Rim e Hipertensão 1209 participants Est. completion 2021-08-23 1 site
    Other conditions: Kidney Transplant Infection
    View official trial listing →
  • Completed NCT NCT03513328

    Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

    Not yet reported, Not yet reported University of Florida 6 participants Est. completion 2023-02-19 1 site Stand-alone
    Other conditions: Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease, Diamond Blackfan Anemia, Acquired Neutropenia in Newborn, Acquired Anemia Hemolytic, Acquired Thrombocytopenia, Hemophagocytic Lymphohistiocytoses, Wiskott-Aldrich Syndrome, Chronic Granulomatous Disease, Common Variable Immunodeficiency, X-linked Lymphoproliferative Disease, Severe Combined Immunodeficiency, Hurler Syndrome, Mannosidosis, Adrenoleukodystrophy
    View official trial listing →
  • Active, not recruiting NCT NCT03597594

    Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)

    Not yet reported, Not yet reported St. Jude Children's Research Hospital 4 participants Est. completion 2028-07-01 1 site
    Other conditions: Severe Combined Immunodeficiency
    View official trial listing →
  • Terminated NCT NCT03600909

    A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia

    Not yet reported Memorial Sloan Kettering Cancer Center 3 participants Est. completion 2021-04-09 3 sites Stand-alone
    Other conditions: Fanconi Anemia, Myelodysplastic Syndrome (MDS), Acute Myelogenous Leukemia (AML)
    View official trial listing →
  • Withdrawn NCT NCT03605654

    Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants

    Not yet reported, Not yet reported Medeor Therapeutics, Inc. Est. completion 2026-10
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Withdrawn NCT NCT03606746

    Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants

    Not yet reported Medeor Therapeutics, Inc. Est. completion 2025-10 Stand-alone
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Terminated NCT NCT03615105

    Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors

    Not yet reported Memorial Sloan Kettering Cancer Center 9 participants Est. completion 2024-03-06 1 site Stand-alone
    Other conditions: Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT03615144

    TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

    Not yet reported Memorial Sloan Kettering Cancer Center 1 participants Est. completion 2020-11-13 1 site
    Other conditions: Non-Malignant Hematologic Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT03622788

    Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 16 participants Est. completion 2027-12-01 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia, Bone Marrow Failure, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Follicular Lymphoma, Hodgkin Lymphoma, Mantle Cell Lymphoma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT03663335

    Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 418 participants Est. completion 2021-10-29 74 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT03663933

    Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

    Not yet reported National Cancer Institute (NCI) 71 participants Est. completion 2030-04-03 2 sites Stand-alone
    Other conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders, Immune System Diseases, Common Variable Immunodeficiency
    View official trial listing →
  • Status unknown NCT NCT03689465

    PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

    Not yet reported Nanfang Hospital, Southern Medical University 260 participants Est. completion 2020-12-31 7 sites
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT03734601

    Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

    Not yet reported Stanford University 22 participants Est. completion 2020-11-17 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorder, Chronic Lymphocytic Leukemia, B-cell Lymphoma, T-cell Lymphoma, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Status unknown NCT NCT03789006

    Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation

    Not yet reported University of Khartoum 300 participants Est. completion 2024-03-21 1 site
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Completed NCT NCT03828058

    Envarsus XL Immunosuppression Following Liver Transplantation

    Not yet reported Methodist Healthcare - Memphis 110 participants Est. completion 2020-12-31 1 site
    Other conditions: Recipients of Liver Transplant
    View official trial listing →
  • Status unknown NCT NCT03828682

    Veloxis de Novo Kidney Transplant ECSWD

    Not yet reported Simon Tremblay, PharmD, PhD 60 participants Est. completion 2022-06-30 2 sites
    Other conditions: Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Active, not recruiting NCT NCT03841097

    Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants

    Not yet reported Roy D. Bloom, MD 60 participants Est. completion 2026-12 1 site
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Active, not recruiting NCT NCT03849651

    TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 69 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), NK-Cell Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma (NHL), Juvenile Myelomonocytic Leukemia (JMML), Chronic Myeloid Leukemia (CML)
    View official trial listing →
  • Terminated NCT NCT03963024

    Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT

    Not yet reported IRCCS San Raffaele 9 participants Est. completion 2019-01-31 1 site
    Other conditions: Irradiated Bone Marrow, Transplant-Related Hematologic Malignancy, Leukemia, Acute, Multiple Myeloma, Graft Vs Host Disease
    View official trial listing →
  • Status unknown NCT NCT03996278

    Comparison Thymoglobulin® and Grafalon®

    University Hospital, Brest 300 participants Est. completion 2021-11-22 13 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT04009525

    Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

    Not yet reported First Affiliated Hospital of Guangxi Medical University 823 participants Est. completion 2023-10-31 1 site
    Other conditions: Thalassemia Major
    View official trial listing →
  • Completed NCT NCT04046549

    A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

    Not yet reported Amgen 25 participants Est. completion 2023-03-22 4 sites
    Other conditions: Allografts, Rejection; Transplant, Kidney, Transplant Rejection, Kidney Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT04098393

    Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

    Not yet reported Memorial Sloan Kettering Cancer Center 39 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Terminated NCT NCT04118556

    Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT

    Not yet reported Mats Remberger 12 participants Est. completion 2026-04-29 4 sites
    Other conditions: GVHD, Acute
    View official trial listing →
  • Active, not recruiting NCT NCT04202835

    ATG Plus PTCy vs ATG for CGVHD Prophylaxis

    Not yet reported McMaster University 80 participants Est. completion 2026-02-07 9 sites Stand-alone
    Other conditions: Acute Leukemia, Myelodysplasia, Chronic Graft-versus-host-disease
    View official trial listing →
  • Terminated NCT NCT04203017

    Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis

    Not yet reported St. Petersburg State Pavlov Medical University 20 participants Est. completion 2023-11-29 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT04328727

    Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

    Not yet reported Novartis Pharmaceuticals 36 participants Est. completion 2024-12-06 12 sites Stand-alone
    Other conditions: Severe Aplastic Anemia (SAA)
    View official trial listing →
  • Active, not recruiting NCT NCT04395222

    Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation

    Not yet reported Weill Medical College of Cornell University 21 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Hematologic Malignancy, Bone Marrow Transplant
    View official trial listing →
  • Status unknown NCT NCT04414735

    Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

    Not yet reported Fundacion Clinic per a la Recerca Biomédica 30 participants Est. completion 2025-12 1 site
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Completed NCT NCT04464434

    Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

    Not yet reported UMC Utrecht 60 participants Est. completion 2026-03-19 8 sites
    Other conditions: Systemic Sclerosis, Systemic Scleroses, Diffuse, Scleroderma, Scleroderma, Diffuse, Autologous Stem Cell Transplantation, Cyclophosphamide, Mycophenolate Mofetil, Treatment Strategy
    View official trial listing →
  • Withdrawn NCT NCT04521946

    Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

    Not yet reported M.D. Anderson Cancer Center Est. completion 2022-12-20
    Other conditions: Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, Central Nervous System Germ Cell Tumor, Choroid Plexus Carcinoma, Intracranial Myeloid Sarcoma, Malignant Brain Neoplasm, Malignant Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, Recurrent Anaplastic Ependymoma, Recurrent Atypical Teratoid/Rhabdoid Tumor, Recurrent Malignant Brain Neoplasm, Recurrent Malignant Glioma, Recurrent Medulloblastoma, Recurrent Primitive Neuroectodermal Tumor
    View official trial listing →
  • Terminated NCT NCT04530487

    Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

    Not yet reported M.D. Anderson Cancer Center 1 participants Est. completion 2024-08-26 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small Round Cell Tumor, Recurrent Malignant Peripheral Nerve Sheath Tumor, Recurrent Malignant Solid Neoplasm, Recurrent Neuroblastoma, Refractory Desmoplastic Small Round Cell Tumor, Refractory Malignant Peripheral Nerve Sheath Tumor, Refractory Malignant Solid Neoplasm, Refractory Neuroblastoma
    View official trial listing →
  • Active, not recruiting NCT NCT04540380

    Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2027-06 1 site
    Other conditions: Renal Failure
    View official trial listing →
  • Status unknown NCT NCT04688021

    A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

    Not yet reported Yi Luo 46 participants Est. completion 2024-12-31 1 site
    Other conditions: Leukemia, Graft-versus-host-disease
    View official trial listing →
  • Terminated NCT NCT04773392

    Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

    Not yet reported University of Southern California 20 participants Est. completion 2024-02-23 1 site
    Other conditions: Kidney Transplantation, Kidney Transplant Rejection
    View official trial listing →
  • Withdrawn NCT NCT04776850

    Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies

    Not yet reported M.D. Anderson Cancer Center Est. completion 2022-12-05
    Other conditions: Beta Thalassemia Major, Sickle Beta 0 Thalassemia, Sickle Beta Plus Thalassemia, Sickle Beta Thalassemia, Sickle Cell Disease, Sickle Cell-SS Disease
    View official trial listing →
  • Status unknown NCT NCT04778618

    Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

    Not yet reported Chinese PLA General Hospital 63 participants Est. completion 2024-01-14 1 site
    Other conditions: Haploidentical Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT04835948

    Efficacy of Single Dose Anti-thymocyte Globulin in the Modulation of T Lymphocytes in Kidney Transplantation

    Hospital de Clinicas de Porto Alegre 200 participants Est. completion 2021-04-13 1 site
    Other conditions: Kidney Transplant; Complications, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT04849533

    Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial)

    Not yet reported University of Cincinnati 120 participants Est. completion 2024-07 2 sites
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Active, not recruiting NCT NCT04872595

    A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

    Not yet reported Memorial Sloan Kettering Cancer Center 59 participants Est. completion 2027-04 1 site
    Other conditions: Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), Myelodysplastic Syndromes (MDS)
    View official trial listing →
  • Withdrawn NCT NCT04903054

    Selective CD28 Blockade in Renal Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2022-09-22 1 site
    Other conditions: Kidney Transplantation, Renal Transplant Recipients
    View official trial listing →
  • Status unknown NCT NCT04945096

    Outcomes of Patients After Allo-HSCT With Decitabine and NAC

    Not yet reported The First Affiliated Hospital of Soochow University 100 participants Est. completion 2025-12-01 Stand-alone
    Other conditions: Engraft Failure, Relapse, GVHD
    View official trial listing →
  • Completed NCT NCT04965597

    Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

    Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2026-02-18 24 sites
    Other conditions: Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia, Hereditary Sideroblastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Shwachman-Diamond Syndrome, Hematologic Neoplasm With Germline GATA2 Mutation, Hematologic Neoplasm With Germline SAMD9 Mutation, Hematologic Neoplasm With Germline SAMD9L Mutation
    View official trial listing →
  • Completed NCT NCT05029206

    Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden

    Uppsala University 174 participants Est. completion 2022-09-30 8 sites
    Other conditions: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Active, not recruiting NCT NCT05132166

    A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease

    Not yet reported University Health Network, Toronto 50 participants Est. completion 2026-04-26 1 site
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05156710

    BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)

    Not yet reported Sanofi 48 participants Est. completion 2026-10-20 27 sites
    Other conditions: Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT05199103

    Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy

    Not yet reported Medical University of Silesia 20 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Graves Orbitopathy
    View official trial listing →
  • Status unknown NCT NCT05214066

    Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT

    Not yet reported Chinese PLA General Hospital 60 participants Est. completion 2022-08-01 1 site Stand-alone
    Other conditions: aGVHD, cGVHD
    View official trial listing →
  • Withdrawn NCT NCT05293509

    Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

    Not yet reported M.D. Anderson Cancer Center Est. completion 2023-09-18 1 site Stand-alone
    Other conditions: Stem Cell Transplantation
    View official trial listing →
  • Terminated NCT NCT05298358

    RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 participants Est. completion 2024-11-21 1 site
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Not yet recruiting NCT NCT05303727

    Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 64 participants Est. completion 2027-08 1 site
    Other conditions: Neuroblastoma
    View official trial listing →
  • Active, not recruiting NCT NCT05457556

    Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome

    Not yet reported Children's Oncology Group 66 participants Est. completion 2027-07-07 63 sites
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Withdrawn NCT NCT05482542

    Optimal Conditioning Regimen for Autologous Transplantation of Relapsing Remitting Multiple Sclerosis

    Not yet reported Scripps Health Est. completion 2027-07-01 1 site
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Active, not recruiting NCT NCT05600426

    A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

    Not yet reported Boston Children's Hospital 53 participants Est. completion 2029-12 52 sites
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT05634915

    Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation

    Not yet reported The First Affiliated Hospital of Soochow University 90 participants Est. completion 2025-05-01 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation, Acute Leukemia
    View official trial listing →
  • Completed NCT NCT05669001

    A Study of TCD601 in de Novo Renal Transplant Recipients

    Not yet reported ITB-Med LLC 76 participants Est. completion 2026-04-10 18 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT05996393

    CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly

    Not yet reported Peking Union Medical College Hospital 86 participants Est. completion 2025-02-27 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Active, not recruiting NCT NCT06039020

    ATGAM General Investigation

    Pfizer 1 participants Est. completion 2027-01-22 1 site
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT06066255

    PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM

    Not yet reported Institut Paoli-Calmettes 27 participants Est. completion 2026-03-31
    Other conditions: Hematological Malignancy
    View official trial listing →
  • Status unknown NCT NCT06075212

    Immune Reconstitution After Allo-HSCT and Blinatumomab

    Sichuan University 20 participants Est. completion 2024-09-30
    Other conditions: Leukemia, Lymphoid
    View official trial listing →
  • Completed NCT NCT06087003

    Pediatric Induction Therapy in Kidney Transplantation

    Gang Chen 958 participants Est. completion 2023-09-30 5 sites
    Other conditions: Kidney Transplant Rejection, Pediatric Kidney Disease
    View official trial listing →
  • Active, not recruiting NCT NCT06098326

    CyFluATG in Lower Risk MDS

    Not yet reported Asan Medical Center 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT06238245

    Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

    Not yet reported Beijing 302 Hospital 22 participants Est. completion 2026-06-30 Stand-alone
    Other conditions: Graft-versus-host Disease, Hematological Malignancies
    View official trial listing →
  • Not yet recruiting NCT NCT06741813

    Allo-HSCT vs ASCT in Adult T-LBL

    Not yet reported Peking University People's Hospital 230 participants Est. completion 2029-12-31
    Other conditions: T Lymphoblastic Lymphoma
    View official trial listing →
  • Completed NCT NCT07155382

    Allogeneic HCT Using Conditioning Regimen of BuFluATG for AML CR1

    Asan Medical Center 98 participants Est. completion 2024-08-22 1 site
    Other conditions: Acute Myeloid Leukemia (AML)
    View official trial listing →
  • Not yet recruiting NCT NCT07203664

    Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.

    Not yet reported Hospital Universitario La Paz 30 participants Est. completion 2026-12-31 1 site
    Other conditions: Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients
    View official trial listing →
  • Not yet recruiting NCT NCT07297550

    Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic Anemia

    Not yet reported, Not yet reported Institute of Hematology & Blood Diseases Hospital, China 42 participants Est. completion 2027-07-01 Stand-alone
    Other conditions: Severe Aplastic Anemia, Refractory Aplastic Anemia, Newly Diagnosed Aplastic Anemia
    View official trial listing →
  • Not yet recruiting NCT NCT07338422

    HID-HSCT Versus IST as First-line Treatment for SAA

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 116 participants Est. completion 2030-09-14
    Other conditions: Aplastic Anaemia
    View official trial listing →
  • Not yet recruiting NCT NCT07440654

    Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis

    Not yet reported Nanfang Hospital, Southern Medical University 40 participants Est. completion 2029-12-01
    Other conditions: aGVHD Prophylaxis
    View official trial listing →
  • Not yet recruiting NCT NCT07562568

    SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

    Not yet reported The First Affiliated Hospital of Soochow University 160 participants Est. completion 2030-06 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell, Conditioning Therapy, SHR2554, Azacytidine
    View official trial listing →
  • Not yet recruiting NCT NCT07634562

    TLI- and ATG-Enabled Minimization Protocol in Liver Transplantation

    Not yet reported, Not yet reported Stanford University 12 participants Est. completion 2031-08 1 site Stand-alone
    Other conditions: Liver Failure
    View official trial listing →
  • Not yet recruiting NCT NCT07717164

    PRAISE-IR Versus CIBMTR Controls

    Miltenyi Biomedicine GmbH 51 participants Est. completion 2026-09-30 1 site
    Other conditions: ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myeloid Leukemia), MDS (Myelodysplastic Syndrome)
    View official trial listing →
  • Not yet recruiting NCT NCT07796620

    Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNI

    Not yet reported, Not yet reported Peking University People's Hospital 40 participants Est. completion 2028-09-30 Stand-alone
    Other conditions: Acute Leukemia, Myelodysplastic Syndromes, Severe Aplastic Anemia (SAA)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Anti-thymocyte globulin, Anti-thymocyte globulin (rabbit), Thymoglobulin®, rabbit ATG

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.